SCHEMBL23609281

SCHEMBL23609281

CC(C)(C)OC(=O)N(CC1CCCCC1)c1ccc([N+](=O)[O-])c(Br)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.38
CHRM2 P08172 2/20 0.37
CHRM1 P11229 2/20 0.37
CHRM3 P20309 2/20 0.37
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
GAA P10253 1/20 0.34
CYP19A1 P11511 3/20 0.34
HDAC8 Q9BY41 1/20 0.33
THRB P10828 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23579269 0.83 PDK1 (0.39) CHRM2CHRM1CHRM3PDK1PDK2
SCHEMBL29973147 0.83 PDK1 (0.39) CHRM2CHRM1CHRM3PDK1PDK2
SCHEMBL23579395 0.79 NPC1 (0.35) CHRM2CHRM1CHRM3NPC1RAB9A
SCHEMBL23579126 0.78 CYP19A1 (0.52) KMT2AMEN1CYP19A1THRBALDH1A1
SCHEMBL29974288 0.78 CYP19A1 (0.52) KMT2AMEN1CYP19A1THRBALDH1A1
SCHEMBL6501239 0.75 PDK1 (0.41) CHRM2CHRM1CHRM3KMT2AMEN1
SCHEMBL1439823 0.75 AAK1 (0.36) KMT2AHDAC8STAT3HTR2CSLC6A4
SCHEMBL6493051 0.75 PDK1 (0.39) CHRM2CHRM1CHRM3PDK1PDK2
SCHEMBL23247020 0.74 MAPT (0.41) ARGAAALDH1A1MAPT
SCHEMBL22897646 0.74 ALDH1A1 (0.39) KMT2AMEN1GAATHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081199-A2 LIPOXYGENASE INHIBITORS SRI International (US) 2022-11-02 EP disclosed
WO-2021133689-A2 LIPOXYGENASE INHIBITORS SRI INTERNATIONAL (US) 2021-07-01 WO disclosed